Effects of astragaloside IV on the pharmacokinetics of puerarin in rats

References

• Binkhathlan Z, Lavasanifar A. (2013). P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Curr Cancer Drug Targets 13:326–46.
   PubMed Web of Science ®Google Scholar
• Deng B, Jia L, Cheng Z. (2016). Radix Astragali-based Chinese herbal medicine for oxaliplatin-induced peripheral neuropathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2016:2421876.
   PubMed Web of Science ®Google Scholar
• Guerra MC, Speroni E, Broccoli M, et al. (2000). Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci 67:2997–3006.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Yokoyama T, Masaoka Y, et al. (2011). Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation. Eur J Pharm Sci 44:544–51.
   PubMed Web of Science ®Google Scholar
• Kim RB, Fromm MF, Wandel C, et al. (1998). The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289–94.
   PubMed Web of Science ®Google Scholar
• Kim SB, Yoon IS, Kim KS, et al. (2014). In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Planta Med 80:561–17.
   PubMed Web of Science ®Google Scholar
• Kopecna-Zapletalova M, Krasulova K, Anzenbacher P, et al. (2017). Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities. Xenobiotica 47:324–31.
   PubMed Web of Science ®Google Scholar
• Li H, Chen B, Pang G, et al. (2016). Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism. Pharm Biol 54:111–7.
   PubMed Web of Science ®Google Scholar
• Li J, Huang L, Wang S, et al. (2016). Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice. Pharm Biol 54:3217–25.
   PubMed Web of Science ®Google Scholar
• Liang XL, Zhang J, Zhao GW, et al. (2015). Mechanisms of improvement of intestinal transport of baicalin and puerarin by extracts of Radix Angelicae Dahuricae. Phytother Res 29:220–7.
   PubMed Web of Science ®Google Scholar
• Liang YZ, Chen HM, Su ZQ, et al. (2014). White pepper and piperine have different effects on pharmacokinetics of puerarin in rats. Evid Based Complement Alternat Med 2014:796890
   PubMed Web of Science ®Google Scholar
• Liao ZG, Liang XL, Zhu JY, et al. (2014). Transport properties of puerarin and effect of extract of Radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models. Phytother Res 28:1288–94.
   PubMed Web of Science ®Google Scholar
• Liu CM, Ma JQ, Sun YZ. (2011). Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. Food Chem Toxicol 49:3119–27.
   PubMed Web of Science ®Google Scholar
• Luo Y, Qin Z, Hong Z, et al. (2004). Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 363:218–23.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807.
   PubMed Web of Science ®Google Scholar
• Tan C, Wang A, Liu C, et al. (2017). Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension. Am J Chin Med 45:1169–84.
   PubMed Web of Science ®Google Scholar
• Wei SY, Chen Y, Xu XY. (2014). Progress on the pharmacological research of puerarin: a review. Chin J Nat Med 12:407–14.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. (2001). Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem 1:403–25.
   PubMedGoogle Scholar
• Zhang G, Ou R, Li F, et al. (2016). Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: implication for clinical drug-drug interactions. J Ethnopharmacol 180:104–13.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang L, Zhang Q, et al. (2011). Puerarin: a novel antagonist to inward rectifier potassium channel (IK1). Mol Cell Biochem 352:117–23.
   PubMed Web of Science ®Google Scholar
• Zhang WD, Zhang C, Liu RH, et al. (2006). Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci 79:808–15.
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Hufnagl P, Binder BR, Wojta J. (2003). Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 90:904–14.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Wang Y, Wang H, Feng L. (2017a). Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats. Xenobiotica 48:1157–63.
   PubMed Web of Science ®Google Scholar
• Zhao WX, Cui N, Jiang HQ, et al. (2017b). Effects of Radix Astragali and its split components on gene expression profiles related to water metabolism in rats with the dampness stagnancy due to spleen deficiency syndrome. Evid Based Complement Alternat Med 2017:1. 4946031.
   Web of Science ®Google Scholar
• Zhou YX, Zhang H, Peng C. (2014). Puerarin: a review of pharmacological effects. Phytother Res 28:961–75.
   PubMed Web of Science ®Google Scholar
• Zhu ML, Liang XL, Zhao LJ, et al. (2013). Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model. J Ethnopharmacol 150:553–9.
   PubMed Web of Science ®Google Scholar